Video Experimental Relacionado
Updated: Aug 12, 2026
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Tratamiento de las hemorroides en pacientes con enfermedad inflamatoria intestinal
Lancet (London, England)
|May 21, 1977
Resumen
El tratamiento de las hemorroides en pacientes con colitis ulcerosa es generalmente seguro, con bajas tasas de complicaciones. Sin embargo, el tratamiento de las hemorroides en pacientes con enfermedad de Crohn conlleva un alto riesgo de complicaciones y está contraindicado.
Área de la Ciencia:
- Gastroenterología y Gastroenterología.
- Cirugía colorrectal cirugía colorrectal.
Sus antecedentes:
- La enfermedad inflamatoria intestinal (EII), incluida la colitis ulcerosa (UC) y la enfermedad de Crohn (CD), afecta al tracto gastrointestinal.
- Las hemorroides son una comorbilidad común en pacientes con EII.
- La seguridad del tratamiento de las hemorroides en pacientes con EII requiere una cuidadosa consideración.
Objetivo del estudio:
- Para evaluar las tasas de complicaciones del tratamiento de las hemorroides en pacientes con colitis ulcerosa y enfermedad de Crohn.
- Determinar la seguridad y eficacia de los tratamientos quirúrgicos y conservadores de las hemorroides en pacientes con EII.
Principales métodos:
- Revisión retrospectiva de 42 pacientes con UC y 20 pacientes con CD tratados por hemorroides entre 1935 y 1975.
- Análisis de las tasas de complicaciones asociadas con tratamientos quirúrgicos y conservadores de hemorroides.
- Evaluación de la necesidad de escisión rectal después del tratamiento de hemorroides.
Principales resultados:
- Los pacientes con colitis ulcerosa experimentaron bajas tasas de complicaciones (4/58 tratamientos).
- Los pacientes con enfermedad de Crohn tenían altas tasas de complicaciones (11/26 tratamientos).
- Seis pacientes con CD requirieron escisión rectal en comparación con un paciente con UC.
Conclusiones:
- El tratamiento de las hemorroides es generalmente seguro para los pacientes con colitis ulcerosa.
- El tratamiento de las hemorroides está contraindicado en pacientes con enfermedad de Crohn debido a los altos riesgos de complicaciones.
Videos de Conceptos Relacionados
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD: